Rhabdomyosarcoma Clinical Trials EU — 8 Studies

Filter these 8 trials by phase, country, sponsor and more.

Open in Search →

Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgery Pending

2024-514089-37-00 4 "Patients with pulmonary metastasis from any primary tumour, "
A trial to determine the dose, and evaluate the safety and pharmacokinetics of lutetium Lu 177 edotreotide in children with somatostatin rec … Recruiting

2024-512831-66-00 3 2025-10-24 "Pediatric participants aged two to less than 18 years old wi"
A clinical study of patritumab deruxtecan (HER3-DXd) in children with cancer (MK-9999-01C) Recruiting

2024-518771-66-00 9 2025-07-01 "Hepatoblastoma, Rhabdomyosarcoma"
Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory s … Recruiting

2024-516392-33-00 5 2021-09-17 "Patients (18-75 years) with metastatic and/or refractory sof"
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 9 2020-10-07 "Rhabdoyosarcoma"
Phase 1/2 Study of Cobolimab plus Dostarlimab in Pediatric and Young Adult Participants with Newly Diagnosed and Relapsed/Refractory Tumors Ended

2024-511350-41-00 9 2025-03-13 "Relapsed/Refractory Tumors"
Study to assess safety and identify dose of ribociclib in combination of temozolomide and topotecan (TOTEM) in patients (12 months – 21 year … Ended

2024-512095-35-00 9 2022-12-27 "Relapsed or refractory neuroblastoma and other solid tumors "
Metro-PD1: a phase I/II trial evaluating anti-PD1 (Nivolumab) in combination with metronomic chemotherapy in children and teenagers with ref … Ended

2024-513470-22-00 9 2019-03-22 "Progressive or refractory paediatric solid tumor"

Showing 1–8 of 8 trials